Actively Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2024-02-16
60000
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand characteristics, treatment patterns, and outcomes for patients in China who have had lung cancers surgically removed. It focuses on how treatments and patient features have changed over time, especially with advances like minimally invasive surgery, targeted therapy, and immunotherapy. The study also seeks to identify factors linked to overall survival and address new clinical questions related to early-stage lung cancer care. The study observes patients diagnosed with lung cancer who have undergone surgical resection at participating medical centers. It collects real-world data from January 2014 through December 2031, including treatment approaches and pathological details. An analytic framework is used to process and ensure the quality of data, supporting the evaluation of survival outcomes and evolving treatment trends. Participants contribute clinical data that is carefully reviewed and analyzed over several years. Researchers will assess baseline characteristics, treatment patterns, and pathological features up to December 2028, with ongoing monitoring of overall survival until the end of 2031. A planned analysis will occur between April and August 2024, with final results expected in 2032. This long-term observational study helps track real-world outcomes in lung cancer patients after surgery.
CONDITIONS
Brief Title
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age above 18
- Have received surgical resection for lung malignancies
You will not qualify if you...
- Participants whose data are of low quality, poor completeness or poor internal linkage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies depending on surgery and recovery
Participants undergo surgical resection of lung cancer and receive immediate post-operative care.
1 surgery and hospital stay
Duration - Up to December 2028
Participants are followed to monitor recovery, treatment patterns, and pathological characteristics after surgery.
Follow-up visits scheduled according to routine clinical care
Duration - January 2014 to December 2031
Participants are monitored for overall survival and long-term outcomes after surgical treatment.
Visits as per standard clinical follow-up
Trial Site Locations
Total: 1 location
1
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China, 100021
Actively Recruiting
Research Team
F
Fengwei Tan, MD-PhD
R
Renda Li, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here